Brady Kathleen T, Sinha Rajita
Clinical Neuroscience Division, Institute of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 69 President St., Charleston, SC 29425, USA.
Am J Psychiatry. 2005 Aug;162(8):1483-93. doi: 10.1176/appi.ajp.162.8.1483.
The high rate of co-occurrence of substance use disorders and other psychiatric disorders is well established. The population of people with co-occurring disorders is heterogeneous, and the prevalence of comorbidity differs by diagnostic group. One of the overarching issues in the area of comorbidity is the nature of the connection between psychiatric disorders and substance use disorders. The rapid development of technical advances in the neurosciences has led to a better understanding of the molecular biology, neurotransmitter systems, and neural circuitry involved in mental illness and substance use disorders. The authors discuss the neurobiological interface between substance use disorders and other psychiatric disorders with an emphasis on emerging data concerning four psychiatric disorders that commonly co-occur with substance use disorders: depression/mood disorders, posttraumatic stress disorder, attention deficit hyperactivity disorder, and schizophrenia. Better understanding of the connection between substance use disorders and psychiatric disorders could have a profound effect on prevention and treatment.
物质使用障碍与其他精神障碍的高共病率已得到充分证实。患有共病的人群具有异质性,且不同诊断组的共病患病率有所不同。共病领域的一个首要问题是精神障碍与物质使用障碍之间联系的本质。神经科学技术的快速发展使人们对涉及精神疾病和物质使用障碍的分子生物学、神经递质系统及神经回路有了更好的理解。作者们讨论了物质使用障碍与其他精神障碍之间的神经生物学界面,重点关注与物质使用障碍常共病的四种精神障碍的新数据:抑郁/情绪障碍、创伤后应激障碍、注意力缺陷多动障碍和精神分裂症。更好地理解物质使用障碍与精神障碍之间的联系可能会对预防和治疗产生深远影响。